Toxoplasmosis in Transplant Recipients, Europe, 2010–2014

Toxoplasmosis in Transplant Recipients, Europe, 2010–2014

Transplantation activity is increasing, leading to a growing number of patients at risk for toxoplasmosis. We reviewed toxoplasmosis prevention practices, prevalence, and outcomes for hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT; heart, kidney, or liver) patients in Euro...

Full description

Bibliographic Details
Main Authors: Florence Robert-Gangneux, Valeria Meroni, Damien Dupont, Françoise Botterel, José M. Aguado Garcia, Marie-Pierre Brenier-Pinchart, Isabelle Accoceberry, Hamdi Akan, Isabella Abbate, Katia Boggian, Fabrizio Bruschi, Jordi Carratalà, Miruna David, Lubos Drgona, Olgica Djurković-Djaković, Maria Carmen Farinas, Francesca Genco, Effrossyni Gkrania-Klotsas, Andreas H. Groll, Edward Guy, Cédric Hirzel, Nina Khanna, Özgür Kurt, Lia Monica Junie, Tiziana Lazzarotto, Oscar Len, Nicolas J. Mueller, Patricia Munoz, Zoi Dorothea Pana, Emmanuel Roilides, Tijana Stajner, Christian van Delden, Isabelle Villena, Hervé Pelloux, Oriol Manuel
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2018-08-01
Series:Emerging Infectious Diseases
Subjects:
toxoplasma infection
transplantation
transplant recipient
cerebral toxoplasmosis
hematopoietic stem cell transplant
chemoprophylaxis
Online Access:https://wwwnc.cdc.gov/eid/article/24/8/18-0045_article
Description
Summary:Transplantation activity is increasing, leading to a growing number of patients at risk for toxoplasmosis. We reviewed toxoplasmosis prevention practices, prevalence, and outcomes for hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT; heart, kidney, or liver) patients in Europe. We collected electronic data on the transplant population and prevention guidelines/regulations and clinical data on toxoplasmosis cases diagnosed during 2010–2014. Serologic pretransplant screening of allo-hematopoietic stem cell donors was performed in 80% of countries, screening of organ donors in 100%. SOT recipients were systematically screened in 6 countries. Targeted anti-Toxoplasma chemoprophylaxis was heterogeneous. A total of 87 toxoplasmosis cases were recorded (58 allo-HSCTs, 29 SOTs). The 6-month survival rate was lower among Toxoplasma-seropositive recipients and among allo-hematopoietic stem cell and liver recipients. Chemoprophylaxis improved outcomes for SOT recipients. Toxoplasmosis remains associated with high mortality rates among transplant recipients. Guidelines are urgently needed to standardize prophylactic regimens and optimize patient management.
ISSN:1080-6040
1080-6059

Similar Items